Technology-assisted Upper Extremity Rehabilitation in Subjects with Incomplete Cervical Spinal Cord Injury (T-ARSCI)

February 23, 2025 updated by: Joonas Poutanen, University of Helsinki

Technology-assisted Upper Extremity Rehabilitation in Subjects with Incomplete Cervical Spinal Cord Injury - Randomized Controlled Crossover Trial

The aim of the study is to investigate the effects of 6 weeks of technological-assisted rehabilitation on function of upper extremity and hand in subjects with incomplete cervical spinal cord injury.

Study Overview

Status

Completed

Detailed Description

In this crossover study, persons with motor incomplete cervical (C2-C8) spinal cord injury (AIS C-D) will be recruited from the Hospital District of Helsinki and Uusimaa. In the first period of the crossover study, other part of the participants will get technological-assisted upper extremity rehabilitation, while the other part of the participants continue their normal lives. The first period is followed by 4-week wash-out period. In the second period, roles of the participants will be switched. The rehabilitation phase lasts for 6 weeks with 3 weekly sessions, each therapy session including at least 30 minutes of technological-assisted upper extremity rehabilitation. Rehabilitation includes passive, active and resistance exercises, and will be carried out by using AMADEO, PABLO and/or DIEGO devices made by Tyromotion.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland
        • Validia Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • incomplete motor spinal cord injury (AIS C-D)
  • injury level C2-C8
  • time since injury from 1 to 5 years
  • to be able to sit
  • motivation and ability to participate in intensive rehabilitation 3 times per week for 6 week period.

Exclusion Criteria:

  • participation in other exercise study or technological-assisted upper extremity study
  • unlikely completion of intervention and participation in follow up
  • injuries that prevent training
  • weak tolerance of intense training
  • severe joint movement restriction or instability
  • irreversible muscle contractures
  • grade 4 on Modified Ashworth Scale in glenohumeral, elbow, wrist and finger joints
  • recent significant forearm or hand injuries
  • memory disorder
  • orthopedic, rheumatic or neurological diseases (other than spinal cord injury) that prevent training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Wait list control
Continue their normal lives.
Experimental: Technology-assisted upper extremity rehabilitation
Technology-assisted upper extremity rehabilitation.
Subjects get 6 weeks of technology-assisted upper extremity rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test (ARAT)
Time Frame: 6 weeks,16 weeks, and 6 months
Maximum score is 114 (on a scale from 0 to 114) as the higher score indicate better upper extremity functioning.
6 weeks,16 weeks, and 6 months
Goal Attainment Scaling (GAS)
Time Frame: 6 weeks or 16 weeks
A method to evaluate rehabilitation effects. A 5-point scale ranging from -2 to 2. Zero represents expected level of performance after rehabilitation, +1 more than expected, and +2 much more than expected. Respectively, -1 means less than expected and -2 much less than expected.
6 weeks or 16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
American Spinal Injury Association - Upper Extremity Motor Scores (ASIA-UEMS)
Time Frame: 6 weeks,16 weeks, and 6 months
Maximum score is 50 (on a scale from 0 to 50) as the higher score indicate better motor functioning in upper extremities.
6 weeks,16 weeks, and 6 months
Grip strength
Time Frame: 6 weeks,16 weeks, and 6 months
Measured with Jamar-dynamometer
6 weeks,16 weeks, and 6 months
Pinch strength
Time Frame: 6 weeks,16 weeks, and 6 months
Measured with
6 weeks,16 weeks, and 6 months
Upper extremity active range of motion
Time Frame: 6 weeks,16 weeks, and 6 months
Measured with goniometer
6 weeks,16 weeks, and 6 months
Spinal Cord Independence Measure - Self Report (SCIM-SR)
Time Frame: 6 weeks,16 weeks, and 6 months
Maximum score is 100 (on a scale from 0 to 100) as the higher score indicate better functioning.
6 weeks,16 weeks, and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sinikka Hiekkala, PhD, The Finnish Association of People with Physical Disabilities

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2021

Primary Completion (Actual)

August 28, 2024

Study Completion (Actual)

August 28, 2024

Study Registration Dates

First Submitted

February 6, 2021

First Submitted That Met QC Criteria

February 15, 2021

First Posted (Actual)

February 18, 2021

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 23, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Technology-assisted upper extremity rehabilitation

Subscribe